SCHEMBL25948141

SCHEMBL25948141

CN(C)C(=O)/C=C/CCCC(=O)Nc1cccn(Cc2nc3cc(F)c(F)c(OCc4ccc(F)cc4F)c3[nH]2)c1=O

nearest known ligand 0.59

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
MAP4K1 Q92918 20/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25942128 0.91 MAP4K1 (0.62) MAP4K1
SCHEMBL25948136 0.91 MAP4K1 (0.63) MAP4K1
SCHEMBL25942409 0.90 MAP4K1 (0.60) MAP4K1
SCHEMBL21703171 0.87 MAP4K1 (0.61) MAP4K1
SCHEMBL25948132 0.87 MAP4K1 (0.63) MAP4K1
SCHEMBL21683899 0.87 MAP4K1 (0.64) MAP4K1
SCHEMBL21683903 0.87 MAP4K1 (0.64) MAP4K1
SCHEMBL21683894 0.87 MAP4K1 (0.64) MAP4K1
SCHEMBL25948149 0.86 MAP4K1 (0.55) MAP4K1
SCHEMBL23452890 0.86 MAP4K1 (0.71) MAP4K1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4219460-A1 TRANSGLUTAMINASE 2 (TG2) INHIBITORS Sitari Pharma, Inc. (US) 2023-08-02 EP disclosed